Cost-effectiveness analysis of clopidogrel in acute coronary syndromes without ST-segment elevation in the Netherlands

被引：5
|
作者：
van Hout, BA
Tangelder, MJD
Bervoets, P
Gabriel, S
机构：
[1] Pharmerit, Capelle aan den IJssel, Netherlands
[2] Sanofi Synthelabo, Maassluis, Netherlands
[3] Bristol Myers Squibb Co, Woerden, Netherlands
[4] Sanofi Synthelabo, Bagneux, France
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61707-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：667 / 668
页数：2
相关论文
共 50 条
  • [1] The cost-effectiveness of clopidogrel in acute coronary syndromes without st-segment elevation in Poland
    Pietrasik, A
    Niewada, M
    Spiesser, J
    Gabriel, S
    VALUE IN HEALTH, 2004, 7 (06) : 687 - 687
  • [2] Cost-effectiveness analysis of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in Hungary
    Borsos, K
    Nagy, B
    Spiesser, J
    Gabriel, S
    Blaskó, G
    VALUE IN HEALTH, 2005, 8 (06) : A88 - A88
  • [3] Modeling the cost-effectiveness of clopidogrel in acute coronary syndromes without ST-segment elevation in Sweden
    Lindgren, P
    Jonsson, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 540A - 540A
  • [4] Cost-effectiveness analysis of clopidogrel in acute coronary syndromes without ST-segment elevation: a five European countries analysis
    Annemans, L
    Lindgren, P
    Frei, A
    Gabriel, S
    Carita, P
    EUROPEAN HEART JOURNAL, 2003, 24 : 586 - 586
  • [5] Clopidogrel effect in patients with acute coronary syndromes without ST-segment elevation
    de Prado, AP
    Fernandez-Vazquez, F
    Ramon, JCC
    Alonso-Orcajo, N
    Vicente, CP
    de Blas, RC
    Nieto, AD
    Castro, AD
    Rodriguez, DA
    Lampin, BS
    Gomez, CO
    Calabozo, RG
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 104H - 105H
  • [6] Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation
    Weintraub, WS
    Mahoney, EM
    Lamy, A
    Culler, S
    Yuan, Y
    Caro, J
    Gabriel, S
    Yusuf, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (06) : 838 - 845
  • [7] Cost-Effectiveness of Fondaparinux in Patients with Acute Coronary Syndrome without ST-Segment Elevation
    Pepe, Camila
    Machado, Marcio
    Olimpio, Alexandre
    Ramos, Rui
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2012, 99 (01) : 613 - 622
  • [8] Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany
    B. Brüggenjürgen
    P. Lindgren
    B. Ehlken
    H.-J. Rupprecht
    S. N. Willich
    The European Journal of Health Economics, 2007, 8 : 51 - 57
  • [9] Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany
    Brueggenjuergen, B.
    Lindgren, P.
    Ehlken, B.
    Rupprecht, H. -J.
    Willich, S. N.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2007, 8 (01): : 51 - 57
  • [10] Long-term cost-effectiveness of Clopidogrel® in patients with acute coronary syndrome without ST-segment elevation in Germany
    Brüggenjürgen, B
    Ehlken, B
    VALUE IN HEALTH, 2004, 7 (06) : 686 - 686
12345